LACOSAMIDE
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
31722-812 -
Package NDC
31722-812-05 -
Package NDC
31722-812-18 -
Package NDC
31722-812-32 -
Package NDC
31722-812-60 -
Application number
ANDA204787 -
SPL ID
54d629b7-e234-69f1-e063-6294a90ab0e7 -
SPL set ID
c5b91128-f838-4e98-9684-5f477fc7af06 -
UNII
563KS2PQY5 -
RxCUI
809987 -
RxCUI
809992 -
RxCUI
809996 -
RxCUI
810000
What the source publishes
- Labeler
- Camber Pharmaceuticals, Inc.
- Active ingredients
- LACOSAMIDE
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "LACOSAMIDE",
"splId": "54d629b7-e234-69f1-e063-6294a90ab0e7",
"labels": [
{
"setId": "c5b91128-f838-4e98-9684-5f477fc7af06",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=c5b91128-f838-4e98-9684-5f477fc7af06",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=c5b91128-f838-4e98-9684-5f477fc7af06"
}
],
"routes": [
"ORAL"
],
"labeler": "Camber Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "500 TABLET, FILM COATED in 1 BOTTLE (31722-812-05)",
"package_ndc": "31722-812-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20220317"
},
{
"sample": false,
"description": "180 TABLET, FILM COATED in 1 BOTTLE (31722-812-18)",
"package_ndc": "31722-812-18",
"identifierStatus": "well-formed",
"marketing_start_date": "20220317"
},
{
"sample": false,
"description": "100 TABLET, FILM COATED in 1 BLISTER PACK (31722-812-32)",
"package_ndc": "31722-812-32",
"identifierStatus": "well-formed",
"marketing_start_date": "20220317"
},
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE (31722-812-60)",
"package_ndc": "31722-812-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20220317"
}
],
"productId": "31722-812_54d629b7-e234-69f1-e063-6294a90ab0e7",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "31722-812",
"deaSchedule": "CV",
"genericName": "LACOSAMIDE",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LACOSAMIDE",
"strength": "50 mg/1"
}
],
"applicationNumber": "ANDA204787",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220317",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000008486"
],
"upc": [
"0331722815604",
"0331722813600",
"0331722814607",
"0331722812603"
],
"unii": [
"563KS2PQY5"
],
"rxcui": [
"809987",
"809992",
"809996",
"810000"
],
"spl_set_id": [
"c5b91128-f838-4e98-9684-5f477fc7af06"
],
"pharm_class_pe": [
"Decreased Central Nervous System Disorganized Electrical Activity [PE]"
],
"manufacturer_name": [
"Camber Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:31722-812_54d629b7-e234-69f1-e063-6294a90ab0e7"